Journal article

A Randomized Phase II Trial of Two Regimens of Moderate Dose Chemoradiation Therapy for Patients with Non-small Cell Lung Cancer Not Suitable for Curative Therapy Trans Tasman Radiation Oncology Study TROG 03.07

Bryan H Burmeister, Michael Michael, Elizabeth Burmeister, Sharon Cox, Margot Lehman, Andrew Wirth, Keith Horwood, Giuseppe Sasso, Barham Forouzesh, David Ball

Journal of Thoracic Oncology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2011

DOI: 10.1097/JTO.0b013e31822d53a9

Grants

Funding Acknowledgements

Supported by Queensland and Victorian Cancer Council Multistate Grants.

Citation metrics

2Web of Science
2Scopus

Keywords

Oncology
Feasibility Studies
Dyspnea
Deoxycytidine
Cisplatin
Concurrent
Chemoradiotherapy
Fatigue
Lung Neoplasms
Disease-Free Survival
Aged
Quality of Life
Vinblastine
Aged, 80 and Over
Dose Fractionation
Gemcitabine Plus
Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Treatment Outcome
Science & Technology
Antimetabolites, Antineoplastic
Neoplasm Staging
Dose Fractionation, Radiation
Adult
Thoracic Radiotherapy
Elderly-Patients
Neoplasm Metastasis
Anorexia
Proportional Hazards Models
Chemoradiation Therapy
Southwest-Oncology-Group
Quality-Of-Life
Vinorelbine
Middle Aged
Respiratory System
Humans
Palliative Radiotherapy
Supportive Care
Female
Male
Palliation
Radiation-Therapy
Life Sciences & Biomedicine
Carboplatin
Antineoplastic Combined Chemotherapy Protocols
Moderate Dose Radiation Therapy